A Novel Approach to Predict the Likelihood of Specific Ovarian Tumor Pathology Based on Serum CA-125: A Multicenter Observational Study

Abstract

Our results confirm the limited clinical value of CA-125 for preoperative discrimination between benign and malignant ovarian pathology. We have shown that CA-125 may be used in a different way. By using likelihood reference tables, we believe clinicians will be better able to interpret preoperative serum CA-125 results in patients with adnexal masses.

References

Page 1

	Year	Citations
Statistical Analysis With Missing Data Maureen Lahiff, Roderick J. A. Little, Donald B. Rubin Journal of the American Statistical Association EngineeringEstimation StatisticData PreparationData TreatmentBiostatistics	1989	17.5K
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls Jonathan A C Sterne, Ian R. White, John B. Carlin, BMJ Quantitative MethodsEpidemiologic ResearchPopulation Health SciencesEducationResearch Ethics	2009	6.8K
Density Estimation for Statistics and Data Analysis Khosrow Dehnad, Bernard W. Silverman Technometrics Density EstimationEngineeringEstimation StatisticStatistical InferenceEstimation Theory	1987	3.8K
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer Robert C. Bast, Thomas L. Klug, Elena St. John, New England Journal of Medicine	1983	2.2K
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma Ignace Vergote, Jos De Brabanter, Anthony Fyles, The Lancet MedicineSurgical PathologyEpithelial Ovarian CarcinomaPathologyGynecology	2001	626
Logistic Regression Model to Distinguish Between the Benign and Malignant Adnexal Mass Before Surgery: A Multicenter Study by the International Ovarian Tumor Analysis Group D. Timmerman, A. C. Testa, T. Bourne, Journal of Clinical Oncology	2005	475
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group D. Timmerman, Lieveke Ameye, D. Fischerová, BMJ	2010	463
Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients Craig C. Earle, Deborah Schrag, Bridget A. Neville, JNCI Journal of the National Cancer Institute	2006	411
Cancer Biomarkers: Can We Turn Recent Failures into Success? Eleftherios P. Diamandis JNCI Journal of the National Cancer Institute PathologyTumor BiologyBiomarker (Medicine)OncologyCancer Detection	2010	371
Partially parametric techniques for multiple imputation Nathaniel Schenker, Jeremy M. G. Taylor Computational Statistics & Data Analysis Parametric TechniquesIncompletenessEstimation StatisticKnowledge DiscoveryData Reduction	1996	326

Page 1